11:40 AM EST - CanniMed Therapeutics Inc. : Has initiated production of CanniMed® Capsules, following the receipt of the Production License granted by Health Canada. Subject to Health Canada’s issuance of the required license to sell, CanniMed anticipates the Capsules will be available for patient order by end of calendar 2017. CanniMed Therapeutics Inc.
shares T.CMED are trading up $0.24 at $11.83.
